Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss
Abstract Regulators of G protein signaling (RGS) accelerate the GTPase activity of G proteins to enable rapid termination of the signals triggered by G protein-coupled receptors (GPCRs). Activation of several GPCRs, including cannabinoid receptor 2 (CB2R) and adenosine A1 receptor (A1AR), protects a...
Guardado en:
Autores principales: | Asmita Dhukhwa, Raheem F. H. Al Aameri, Sandeep Sheth, Debashree Mukherjea, Leonard Rybak, Vickram Ramkumar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f7bd4bab02fb490bac2efed2eca9e9b6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A666-conjugated nanoparticles target prestin of outer hair cells preventing cisplatin-induced hearing loss
por: Wang XL, et al.
Publicado: (2018) -
The Outcomes in Patients Treated With Intratympanic and Systemic Steroids for Sudden Hearing Loss and Prognostic Factors
por: Ayse Bel Çeçen, et al.
Publicado: (2021) -
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study
por: A. J. M. Meijer, et al.
Publicado: (2021) -
The Correlation Between Hearing Loss, Especially High-Frequency Hearing Loss and Cognitive Decline Among the Elderly
por: Tongxiang Diao, et al.
Publicado: (2021) -
Hearing aid fitting in older persons with hearing impairment: the influence of cognitive function, age, and hearing loss on hearing aid benefit
por: Meister H, et al.
Publicado: (2015)